Common side effects of<unk> (123I) are headache, vertigo, increased appetite and formication. Less than 1% of patients experience pain at the injection site. The radiation risks are reported as low. The committed effective dose for a single investigation on a 70 kg individual is 4.6 mSv. Pregnant patients should not undergo the test. It is not known if 123I-ioflupane is secreted in breast milk however it is recommended that breastfeeding is interrupted for three days after administration.
Ioflupane 
Enoximone
Norethisterone
Cabergoline
5α-Dihydronorethisterone
Clobetasone
Nandrolone phenylpropionate
Promestriene